(NULG) Nuveen ESG Large-Cap Growth - Ratings and Ratios
Large-Cap, Growth, Equity, ESG, Technology
Dividends
| Dividend Yield | 0.14% |
| Yield on Cost 5y | 0.26% |
| Yield CAGR 5y | -45.24% |
| Payout Consistency | 71.1% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.7% |
| Value at Risk 5%th | 35.6% |
| Relative Tail Risk | 4.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | -6.33 |
| CAGR/Max DD | 1.14 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.400 |
| Beta | 1.096 |
| Beta Downside | 1.038 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.28% |
| Mean DD | 3.08% |
| Median DD | 1.86% |
Description: NULG Nuveen ESG Large-Cap Growth November 13, 2025
Nuveen’s ESG Large-Cap Growth ETF (BATS:NULG) commits at least 80 % of its net assets-plus any borrowed funds-to equities that belong to its ESG-screened index. The index tracks large-capitalization U.S. companies listed on domestic exchanges that satisfy defined environmental, social, and governance criteria, positioning the fund squarely within the large-growth segment.
As of the latest filing, NULG carries an expense ratio of 0.12 % and manages roughly $1.2 billion in assets. Its top ten holdings are dominated by mega-cap tech and consumer-discretionary firms such as Apple, Microsoft, Nvidia, Amazon, and Tesla, which together account for about 45 % of the portfolio. The fund’s sector tilt-≈55 % technology, 20 % consumer discretionary, and 15 % healthcare-means performance is closely tied to U.S. tech earnings growth and the broader macro-trend of rising corporate ESG disclosure standards, both of which have been accelerating under recent SEC guidance.
For a deeper quantitative dive, the ValueRay platform offers granular ESG score breakdowns and back-tested performance metrics for NULG.
What is the price of NULG shares?
Over the past week, the price has changed by -1.91%, over one month by -2.37%, over three months by -1.58% and over the past year by +7.93%.
Is NULG a buy, sell or hold?
What are the forecasts/targets for the NULG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 113.8 | 16.8% |
NULG Fundamental Data Overview December 05, 2025
Beta = 1.16
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.93b USD (1.93b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.93b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.93b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.06% (E(1.93b)/V(1.93b) * Re(10.06%) + (debt-free company))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for NULG ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle